Kymera Therapeutics, Inc. (KYMR) vs TG Therapeutics, Inc. (TGTX)

A side-by-side comparison of Kymera Therapeutics, Inc. and TG Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — KYMR vs TGTX

growth of $100 · dividends reinvested · last 6y
KYMR +230.3% (+22.0%/yr)TGTX +128.7% (+14.8%/yr)KYMR compounded faster over this window
0100200300400Start $100202120222023202420252026$330$229
KYMR TGTX

KYMR vs TGTX: by the numbers

  • •KYMR is the larger company ($8.69B vs $8.04B market cap).
  • •TGTX is profitable (55.22% net margin) while KYMR runs a net loss (-285.41%).
  • •TGTX grew revenue faster over the past five years (219.22% vs 10.22% CAGR).

Metrics side by side

Valuation

MetricKYMRTGTX
P/E ratioN/A19.16
Forward P/EN/A53.93
P/S ratio82.7810.05
P/B ratio5.7613.30
EV / EBITDAN/A60.80
FCF yieldN/A0.22%

Profitability

MetricKYMRTGTX
Gross margin101.98%82.36%
Operating margin-891.33%17.05%
Net margin-285.41%55.22%
ROE-19.85%73.08%
ROIC-22.30%9.94%

Growth (annualized)

MetricKYMRTGTX
Revenue CAGR (5Y)10.22%219.22%
Total return CAGR (5Y)12.31%10.75%

Frequently asked

Which has grown faster, KYMR or TGTX?
Over the past five years, TGTX grew revenue faster — KYMR at a 10.22% CAGR versus TGTX at 219.22%.
Is KYMR or TGTX more profitable?
TGTX runs the higher net margin — KYMR at -285.41% versus TGTX at 55.22%.
How have KYMR and TGTX total returns compared?
Over the past 5 years, KYMR delivered 12.31% and TGTX delivered 10.75% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.